XDXiaowu Deng

Xiaowu Deng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaowu Deng has a total of 116 co-authors. Here are the top co-authors by number of shared publications:

  • Boyu Chen

    State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China

    2 shared publications
  • Chong Zhao

    State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Nasopharyngeal Carcinoma, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Centre, Guangzhou, PR China

    2 shared publications
  • Fei Han

    Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, P.R. China

    2 shared publications
  • Li-Xia Lu

    2 shared publications
  • Lin Wang

    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060 Guangzhou, China

    2 shared publications
  • Meining Chen

    Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

    2 shared publications

Latest Publications

  • MAX-FLASH: A compact multiangle x-ray system for clinical translation of FLASH radiotherapy

    by Focheng Liu, Liang Zhang, Jiaru Shi, Hao Zha, Yinuo Zhu, Qiang Gao, Fusheng Zhang, Ankang Hu, Rui Qiu, Junli Li, et al.


  • Open Access

    Multi-Sequence Fusion Network via Single- Sequence CycleGANs for Improved Synthetic CT in Nasopharyngeal Carcinoma Treatment Planning

    by Yimei Liu, Meining Chen, Jun Zhang, Yixuan Wang, Huikuan Gu, Chong Zhao, Zhenyu Qi, Xiaowu Deng, Shuyu Wu, Yinglin Peng

    To investigate the effect of different MR sequences on the accuracy of Cycle-consistent Generative Adversarial Network (CycleGAN) based synthetic CT (sCT) generation in nasopharyngeal carcinoma (NPC). In this work, three sequences of MR, included T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and T1 contrast-enhanced weighted imaging (T1WIC), and planning CT (PCT) images of 151 patients with NPC were collected. The number of training, verification, and test sets were 108, 16, and 27, respectively. Three unsupervised CycleGAN-based models were trained using different sequences (single channels) as inputs, and the synergistic fusion model were used multiple channels. To assess the precision of these models, we evaluated key metrics such as mean error (ME), mean absolute error (MAE), structural similarity index (SSIM), peak signal-to-noise ratio (PSNR), and dose distribution, comparing the PCT with the sCT generated by each model. Overall, The SCT T2 image generated by T2WI model achieved superior results than those of T1WIC and T1WI for a single-sequence model. Compared to the SCT T2 , the quality of the SCT Fusion image generated by the fusion model was further improved, with significant differences in the MAE, SSIM, and PNSR metrics (P<0.05), the average MAE, SSIM, and PNSR in the body were (112.97±9.69 vs. 90.99±9.64, P<0.05) HU, (0.86±0.02 vs. 0.89±0.02, P<0.05), and (21.66±0.64 vs. 23.28±0.87, P<0.05), respectively. Meanwhile, the average gamma passing rates (3%, 3 mm) and the average absolute dose discrepancies were 99.45% ± 1.05% and 0.73%±0.73% for the fusion model. In conclusion, our findings reveal that the CycleGAN model, particularly when employing fusion MR sequences as input, offers the highest accuracy in synthetic CT generation. Notably, T2WI images stand out as a viable option for sCT prediction in clinical settings where acquisition sequences or times are limited.


  • Open Access

    Commissioning and clinical evaluation of a novel high‐resolution quality assurance digital detector array for SRS and SBRT

    by Yang Zhou, Yimei Liu, Meining Chen, Jianlan Fang, Liangjie Xiao, Shaomin Huang, Zhenyu Qi, Xiaowu Deng, Jun Zhang, Yinglin Peng

    Purpose: We aimed to perform the commissioning and clinical evaluation of myQA SRS detector array for patient‐specific quality assurance (PSQA) of stereotactic radiosurgery (SRS)/ stereotactic body radiotherapy (SBRT) plans.Methods: To perform the commissioning of myQA SRS, its dose linearity, dose‐rate dependence, angular dependence, and field‐size dependence were investigated. Ten SBRT plans were selected for clinical evaluation: 1) Common clinical deviations based on the original SBRT plan (Plan0), including multileaf collimator (MLC) positioning deviation and treatment positioning deviation were introduced. 2) Compared the performance of the myQA SRS and a high‐resolution EPID dosimetry system in PSQA measurement for the SBRT plans. Evaluation parameters include gamma passing rate (GPR) and distance‐to‐agreement (DTA) pass rate (DPR).Results: The dose linearity, angle dependence, and field‐size dependence of myQA SRS system exhibit excellent performance. The myQA SRS is highly sensitive in the detection of MLC deviations. The GPR of (3%/1 mm) decreases from 90.4% of the original plan to 72.7%/62.9% with an MLC outward/inward deviation of 3 mm. Additionally, when the setup error deviates by 1 mm in the X, Y, and Z directions with the GPR of (3%/1 mm) decreasing by an average of −20.9%, −25.7%, and −24.7%, respectively, and DPR (1 mm) decreasing by an average of −33.7%, −32.9%, and −29.8%. Additionally, the myQA SRS has a slightly higher GPR than EPID for PSQA, However, the difference is not statistically significant with the GPR of (3%/1 mm) of (average 90.4%% vs. 90.1%, p = 0.414).Conclusion: Dosimetry characteristics of the myQA SRS device meets the accuracy and sensitivity requirement of PSQA for SRS/SBRT treatment. The dose rate dependence should be adequately calibrated before its application and a more stringent GPR (3%/1 mm) evaluation criterion is suggested when it is used for SRS/SBRT QA.


  • Open Access

    The m6A reader IGF2BP3 preserves NOTCH3 mRNA stability to sustain Notch3 signaling and promote tumor metastasis in nasopharyngeal carcinoma

    by Boyu Chen, Runda Huang, Tianliang Xia, Chunyang Wang, Xiao Xiao, Shunzhen Lu, Xiangfu Chen, Ying Ouyang, Xiaowu Deng, Jingjing Miao, et al.

    Metastasis remains the major cause of treatment failure in patients with nasopharyngeal carcinoma (NPC), in which sustained activation of the Notch signaling plays a critical role. N6-Methyladenosine (m6A)-mediated post-transcriptional regulation is involved in fine-tuning the Notch signaling output; however, the post-transcriptional mechanisms underlying NPC metastasis remain poorly understood. In the present study, we report that insulin-like growth factor 2 mRNA-binding proteins 3 (IGF2BP3) serves as a key m6A reader in NPC. IGF2BP3 expression was significantly upregulated in metastatic NPC and correlated with poor prognosis in patients with NPC. IGF2BP3 overexpression promoted, while IGF2BP3 downregulation inhibited tumor metastasis and the stemness phenotype of NPC cells in vitro and in vivo. Mechanistically, IGF2BP3 maintains NOTCH3 mRNA stability via suppression of CCR4-NOT complex-mediated deadenylation in an m6A-dependent manner, which sustains Notch3 signaling activation and increases the transcription of stemness-associated downstream genes, eventually promoting tumor metastasis. Our findings highlight the pro-metastatic function of the IGF2BP3/Notch3 axis and revealed the precise role of IGF2BP3 in post-transcriptional regulation of NOTCH3, suggesting IGF2BP3 as a novel prognostic biomarker and potential therapeutic target in NPC metastasis.


  • Long noncoding RNA LINC00173 induces radioresistance in nasopharyngeal carcinoma via inhibiting CHK2/P53 pathway

    by Jingjing Miao, Boyu Chen, Yunyun Xiao, Runda Huang, Xiao Xiao, Shunzhen Lu, Lu Zhang, Xuguang Wang, Ying Ouyang, Xiangfu Chen, et al.

    Radiotherapy is the backbone of nasopharyngeal carcinoma (NPC), nearly 11–17% NPC patients suffered local relapse and 18–37% suffered distant metastasis mainly due to radioresistance. Therefore, the key of improving patients’ survivals is to investigate the mechanism of radioresistance. In this study, we revealed that the expression level of long intergenic nonprotein coding RNA 173 (LINC00173) was significantly increased in the radioresistant NPC patients’ tumour tissues compared with the radiosensitive patients by RNA-sequencing, which also predict poor prognosis in NPC. Overexpression of LINC00173 induced radioresistance of NPC cells in vitro and in vivo. Mechanistically, LINC00173 bound with checkpoint kinase 2 (CHK2) in nucleus, and impaired the irradiation-induced CHK2 phosphorylation, then suppressed the activation of P53 signalling pathway, which eventually inhibiting apoptosis and leading to radioresistance in NPC cells. In summary, LINC00173 decreases the occurrence of apoptosis through inhibiting the CHK2/P53 pathway, leads to NPC radioresistance and could be considered as a novel predictor and therapeutic target in NPC.


  • Open Access

    Study on the Impact of Antioxidant on the FLASH Effect With 6 MeV X-Ray

    by H. Zhu, D.H. Xie, Y. Yang, D. Wu, S.M. Huang, X. Gao, Y. Peng, B. Wang, C. Li, J. Wang, et al.


  • Open Access

    Efficacy and safety of primary surgery with postoperative radiotherapy in head and neck mucosal melanoma: a single-arm Phase II study

    by Ji-Jin Yao, Fan Zhang, Guang-Shun Zhang, Xiao-Wu Deng, Wang-Jian Zhang, Wayne R Lawrence, Lu Zou, Xiao-Shi Zhang, Li-Xia Lu

    Background: There still remains no well-established treatment strategy for head and neck mucosal melanoma (HNMM). We aim to evaluate the effectiveness and safety of primary surgery with postoperative radiotherapy for this disease. Patients and methods: A single-arm, Phase II clinical trial was conducted at Sun Yat-Sen University Cancer Center. Patients with nonmetastatic, histologically proven HNMM were prospectively enrolled. Patients received primary surgery followed by intensity-modulated radiotherapy with an equivalent dose at 2 Gy per fraction of 65–70 Gy to CTV1 (high-risk regions including tumor bed) and 50–55 Gy to CTV2 (low-risk regions). Additional use of adjuvant chemotherapy (AC) depended on consultation from a multidisciplinary team. This trial is registered with ClinicalTrials.gov, number NCT03138642. Results: A total of 33 patients were enrolled and analyzed between July 2010 and November 2016. There were 18 (54.5%) patients with T3 disease and 15 (45.5%) patients with T4a disease. The median age at diagnosis was 58 years (range 27–83 years), and 61% of the cohort were males. The overall median follow-up duration was 25.3 months (range 5.3–67.1 months). The 3-year overall survival (OS), local relapse-free survival (LRFS), regional relapse-free survival (RRFS), and distant metastasis-free survival (DMFS) rates were 44.4, 91.7, 78.1, and 41.7%, respectively. Patients with T4a disease showed significantly inferior OS (P=0.049) and DMFS (P=0.040) than those with T3 disease. Prophylactic neck radiation (PNR) was nearly associated with superior RRFS (P=0.078). However, there was no significant difference in OS, LRFS, RRFS, and DMFS for patients treated with or without AC (P>0.05 for all). Toxicities were generally mild to moderate. Conclusion: Primary surgery with postoperative radiotherapy yielded excellent local control and acceptable toxicity profile for HNMM. Nevertheless, high rates of distant metastases resulted in limited survival.


  • Open Access

    Dendritic cells cross-talk with tumour antigen-specific CD8+ T cells, Vγ9γδT cells and Vα24NKT cells in patients with glioblastoma multiforme and in healthy donors

    by Y. Eiraku, H. Terunuma, M. Yagi, X. Deng, A. J. Nicol, M. Nieda

    The finding that dendritic cells (DCs) orchestrate innate and adaptive immune responses has stimulated research on harnessing DCs for developing more effective vaccines for DC therapy. The expression of cytomegalovirus (CMV) antigens in glioblastoma multiforme (GBM) presents a unique opportunity to target these viral proteins for tumour immunotherapy. Here, we demonstrate that Vγ9γδT cells, innate immune cells activated by zoledronate (Z) and Vα24 natural killer (Vα24NK) cells, innate/adaptive immune cells activated by α‐galactosylceramide (G) can link innate and adaptive immunities through cross‐talk with interferon (IFN) DCs from patients with glioblastoma multiforme (GBM) and healthy donors in a manner that can amplify the activation and proliferation of CMVpp65‐specific CD8+ T cells. The IFN DCs derived from patients with GBM used in this study express lower levels of programmed cell death ligand (PD)‐L1 and PD‐L2 and higher levels of C‐C receptor 7 (CCR7) than the most commonly used mature interleukin (IL)‐4 DCs. The expression level of programmed cell death 1 (PD‐1) on CD8+ T cells, including CMVpp65‐specific CD8+ T cells, expanded by IFN DCs pulsed with the CMVpp65‐peptide and Z plus G (IFN DCs/P+Z+G), was lower than that expanded by IFN DCs pulsed with the peptide alone (IFN DCs/P). Multi‐functional T cells, including human leucocyte antigen (HLA)‐A*0201‐restricted CMVpp65‐specific CD8+ T cells, Vγ9γδT cells and Vα24NKT cells, efficiently kill the HLA‐A*0201‐positive GBM cell line expressing CMVpp65 protein (T98G). These findings indicate that DC therapy using IFN DCs/P+Z+G and/or CTL therapy using CMVpp65‐specific CD8+ T cells expanded by IFN DCs/P+Z+G may lead to a good clinical outcome for patients with GBM.


  • Parameter optimization and effective imaging volume determination of helical scan for a pinhole animal SPECT

    by Rutao Yao, Xiao Deng, Tiantian Dai, Qingyang Wei, Jean-François Beaudoin, Charles Naaman, Tianyu Ma, Jules Cadorette, Roger Lecomte

    We developed SPECT imaging capability on a LabPETTM animal scanner. The add-on SPECT uses a multiplepinhole collimator and a step-and-shoot helical scan scheme. The objective of this work was to determine I) the effective imaging volume of a given scan protocol, and 2) the helical scan parameters, that is, the angular and axial step sizes, for achieving uniform high resolution images throughout the imaging volume. Three rotational step sizes, {1°, 2°, 3°}, and three axial step sizes, {0.3 mm, 0.6 mm, 1.2 mm}, were combined to form 9 helical scan protocols. These step sizes were derived based on the reference values analytically calculated using the spatial resolution of the SPECT system and the Nyquist sampling theorem. Two numerical indices, the sampling completeness percentage (SCP), and the directional resolution (DR), were designed to quantify the projection sampling and resolution performance of the helical protocols. Scanning of a digital sphere-grid phantom centered in the SPECT system's FOV was simulated for each of the 9 helical protocols. Aggregated RMS resolution values derived from the image of distributed spheres over the FOV were used to assess the resolution performance of the scan protocols, and for validating the predictive value of the SCP and DR indices, which were calculated over the matching grid. The RMS results showed that the effective image volume of a helical scan where sampling is adequate was defined by the start and end pinhole planes. The results also showed that using a small axial step size (about half the value derived from Nyquist theorem) achieved best imaging resolution, while the angular step size was less critical. The RMS images correlated well with that of SCP and DR. We conclude the following for designing a helical scan protocol with a multiple pinhole collimator. First, the effective imaging volume should be confined between the start and end planes of the pinholes' movement range. Second, using an axial step size that is half of what is calculated from the Nyquist theorem is desirable for optimal resolution performance. In addition, SCP and DR are useful indices for assessing scan protocols analytically.